Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, 450000, China
Location status: Recruiting
NCT Number: NCT07181356
At present, there are 290 million cardiovascular patients in China, including 11 million patients with coronary heart disease. Remote ischemic preconditioning(RIPC) may play an effective endogenous cardiac protection.This study will explore whether long-term use of RIPC in patients with AMI after PCI and non interventional therapy can reduce the incidence of major adverse cardiovascular cerebrovascular events(MACCE) and improve clinical outcomes and long-term prognosis.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Zhengzhou, Henan, 450000, China
Location status: Recruiting
A total of 2146 patients with AMI are expected included as the research objects and randomly divided into experimental group and control group with 1073 cases in each group. After admission, Patients in the experimental group received everyday RIPC of upper limbs to the end of follow-up.The control group is a blank control and undergoes conventional medical procedures. Routine blood indexes, ultrasound, electrocardiogram, were detected On the day of admission. 12 months post- discharge, the incidence of MACCE(include Cardiovascular death, non-fatal acute myocardial infarction, stent thrombosis, revascularization, stroke, admission due to heart failure and the above composite events were independent components) and Poce(All deaths, all strokes, all myocardial infarction, or all revascularization events)will recorded by telephone follow-up.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each 40 minutes treatment time, 10 minutes as a cycle (cuff inflated to 200 mmHg and maintained for 5 minutes, then deflated for 5 minutes to start the next cycle), a total of 4 cycles
Each 40 minutes treatment time, 10 minutes as a cycle (cuff inflated to 200 mmHg and maintained for 5 minutes, then deflated for 5 minutes to start the next cycle), a total of 4 cycles
Time frame: 12 months after discharge
MACCE(include Cardiovascular death, non-fatal acute myocardial infarction, revascularization, stroke, admission due to heart failure )
Time frame: 12 months after discharge
Rate of Cardiovascular death events
Time frame: 12 months after discharge
Rate of non-fatal acute myocardial infarction events
Time frame: 12 months after discharge
Rate of revascularization events
Time frame: 12 months after discharge
Rate of stroke events
Time frame: 12 months after discharge
Rate of admission due to heart failure events
Time frame: 12 months after discharge
Rate of all all-cause death events
Contact information is provided by the study sponsor or research team.
Henan Institute of Cardiovascular Epidemiology
Other
Acronym: L-RICP-AMI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05073419
Acute Myocardial Infarction
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06336317
Acute Myocardial Infarction, Cardiovascular Diseases
Aarhus, Denmark
View Trial DetailsNCT07492537
Acute Myocardial Infarction, Autonomic Nervous System Diseases
Roma, Italia, Italy
View Trial DetailsNCT05185492
Acute Myocardial Infarction, Cardiogenic Shock
Weston, Florida, United States
View Trial Details